phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 and Malignant Melanoma

phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 has been researched along with Malignant Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baker, B; Engel, JB; Halmos, G; Keller, G; Nagy, A; Schally, AV	1

Other Studies

1 other study(ies) available for phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 and Malignant Melanoma

Article	Year
Effective therapy of experimental human malignant melanomas with a targeted cytotoxic somatostatin analogue without induction of multi-drug resistance proteins. International journal of oncology, 2006, Volume: 28, Issue:6 Topics: Amino Acid Sequence; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Cell Line, Tumor; Cell Survival; DNA Primers; Drug Resistance, Multiple; Humans; Kinetics; Melanoma; Mice; Mice, Nude; Octreotide; Polymerase Chain Reaction; Transplantation, Heterologous	2006

Article

Year

Effective therapy of experimental human malignant melanomas with a targeted cytotoxic somatostatin analogue without induction of multi-drug resistance proteins.

International journal of oncology, 2006, Volume: 28, Issue:6

Topics: Amino Acid Sequence; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Cell Line, Tumor; Cell Survival; DNA Primers; Drug Resistance, Multiple; Humans; Kinetics; Melanoma; Mice; Mice, Nude; Octreotide; Polymerase Chain Reaction; Transplantation, Heterologous

2006